T1	Participants 452 607	Eligible patients had painDETECT "unclear" or "positive" ratings and average pain intensity ≥ 6 (11-point NRS-3 [average 3-day pain intensity]) at baseline
T2	Participants 384 442	severe, chronic low back pain with a neuropathic component
